title: Anaplastic large cell lymphoma with axial skeletal lesions portends a poor prognosis.
authors.affiliation: FY1 in Cardiology in the Department of Cardiology, Uxbridge, Middlesex UB8 3NN.
authors.forename: Zahra
authors.initials: Z
authors.lastname: Al-Asaadi
authors.affiliation: Registrar in Haematology, Uxbridge, Middlesex UB8 3NN.
authors.forename: Sammour
authors.initials: S
authors.lastname: Fatin
authors.affiliation: Consultant in Haematology in the Department of Haematology, Uxbridge, Middlesex UB8 3NN.
authors.forename: Ketan
authors.initials: K
authors.lastname: Patel
authors.affiliation: Consultant in Radiology in the Department of Radiology, Uxbridge, Middlesex UB8 3NN.
authors.forename: Naren
authors.initials: N
authors.lastname: Chetty
authors.affiliation: Consultant in Cardiology in the Department of Cardiology, Hillingdon and Mount Vernon Hospitals NHS Trust, Uxbridge, Middlesex UB8 3NN.
authors.forename: Simon
authors.initials: S
authors.lastname: Dubrey
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D017728:Lymphoma, Large-Cell, Anaplastic / Q000175:diagnosis* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D055613:Multiple Pulmonary Nodules / Q000175:diagnosis* / Q000188:drug therapy; D010384:Pelvic Bones / Q000000981:diagnostic imaging* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D000069283:Rituximab / Q000008:administration & dosage; D013125:Spinal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone